Navigation Links
UPDATING and ADDING: Questcor Pharmaceuticals to Present at Upcoming Investor Conferences in September
Date:9/1/2011

and Q&A session on Wednesday, September 14, 2011 at 8:00 a.m. ET.  A live audio only webcast and subsequent archived replay of the discussion will be accessible at http://ir.questcor.com/events.cfm.
  • UBS Global Life Sciences Conference at the Grand Hyatt in New York City.  Mr. Bailey is scheduled to present on Monday, September 19, 2011 at 10:30 a.m. ET.  A live webcast and subsequent archived replay of the presentation will be accessible at http://ir.questcor.com/events.cfm.

  • About Questcor

    Questcor Pharmaceuticals, Inc. is a biopharmaceutical company whose primary product helps patients with serious, difficult-to-treat medical conditions.  Questcor's primary product is H.P. Acthar® Gel (repository corticotropin injection), an injectable drug that is approved by the FDA for the treatment of 19 indications.  Of these 19 indications, Questcor currently generates substantially all of its net sales from three indications: the treatment of acute exacerbations of multiple sclerosis in adults, the treatment of nephrotic syndrome, and the treatment of infantile spasms in children under two years of age. With respect to nephrotic syndrome, the FDA has approved Acthar to "induce a diuresis or a remission of proteinuria in the nephrotic syndrome without uremia of the idiopathic type or that due to lupus erythematosus."  Questcor is also exploring the use of Acthar to treat systemic lupus erythematosus, for which Acthar is approved as both a maintenance therapy and to treat exacerbations.  Questcor is also exploring the possibility of developing markets for other on-label indications and the possibility of pursuing FDA approval of additional indications not currently on the Acthar label where there is high unmet medical need.  For more information, please visit

    SOURCE Questcor Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3

    Related medicine technology :

    1. Questcor Pharmaceuticals to Present at the Canaccord Genuity Growth Conference on August 11, 2011
    2. Questcor to Report Second Quarter 2011 Earnings and Conduct Conference Call on July 26, 2011
    3. Questcor Proxy Proposals All Approved at 2011 Shareholder Meeting
    4. Questcor Discusses ISS Proxy Recommendations; Provides Business Update
    5. Questcor to Report First Quarter 2011 Earnings and Conduct Conference Call on April 26, 2011
    6. Questcor Pharmaceuticals Announces Preliminary Operating Metrics for First Quarter 2011
    7. Questcor Pharmaceuticals to Present at the Needham Healthcare Conference
    8. Questcor Pharmaceuticals to Present at the Barclays Capital Global Healthcare Conference
    9. Questcor Pharmaceuticals Selects BDO USA as its Auditor
    10. Questcor Reports 2010 Financial Results
    11. Questcor to Report Fourth Quarter and Full Year 2010 Earnings and Conduct Conference Call on February 23, 2011
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/2/2015)... July 2, 2015  Fort Lauderdale-based investment banking ... announce that its Consumer Group completed the sale ... Group plc (ISE: KRZ) ("Kerry"), one of the ... systems, as well as functional ingredients and actives ... Farlie Turner served as the exclusive financial advisor ...
    (Date:7/2/2015)... DUBLIN , June 26, 2015 ... of the "Vitamin D Market by Analog, Application, End-User ... report to their offering. This market is ... use of vitamin D in different applications and rising opportunities ... China , Italy , and ...
    (Date:7/2/2015)... Pharma Major Lupin Limited today announced ... Russia subject to certain closing conditions. ... which recorded RUB 765 billion in sales, placing it as ... in 2014 (IMS Health). For over a decade, Russian pharmaceutical ... this trend, projecting Russia to be ...
    Breaking Medicine Technology:Farlie Turner's Consumer Group Completes Sale of Insight Beverages to Kerry 2Vitamin D Market by Analog, Application, End-User & by Region - Global Trends & Forecast to 2020: Increasing Recommendation By Doctors & Associations 2Vitamin D Market by Analog, Application, End-User & by Region - Global Trends & Forecast to 2020: Increasing Recommendation By Doctors & Associations 3Lupin Acquires Biocom in Russia 2Lupin Acquires Biocom in Russia 3
    ... nationally recognized, certified practice management and electronic ... its annual Customer Conference at the Magic City,s renowned ... A record 361 attendees registered for this ... last year,s figures. "Spotlight on Success" was chosen as ...
    ... RIDGEFIELD, Conn., May 19, 2011 Boehringer Ingelheim ... (dabigatran etexilate mesylate) capsules has received preferred ... Part D plans through its pharmacy benefits manager, ... include AARP Medicare Rx and AARP MedicareComplete from ...
    Cached Medicine Technology:SuccessEHS "Spotlight on Success" Customer Conference Begins 2Pradaxa® (dabigatran etexilate mesylate) Capsules Gains Preferred Formulary Status with AARP®, Nation's Largest Provider of Medicare Part D Coverage 2Pradaxa® (dabigatran etexilate mesylate) Capsules Gains Preferred Formulary Status with AARP®, Nation's Largest Provider of Medicare Part D Coverage 3Pradaxa® (dabigatran etexilate mesylate) Capsules Gains Preferred Formulary Status with AARP®, Nation's Largest Provider of Medicare Part D Coverage 4Pradaxa® (dabigatran etexilate mesylate) Capsules Gains Preferred Formulary Status with AARP®, Nation's Largest Provider of Medicare Part D Coverage 5Pradaxa® (dabigatran etexilate mesylate) Capsules Gains Preferred Formulary Status with AARP®, Nation's Largest Provider of Medicare Part D Coverage 6
    (Date:7/2/2015)... , ... July 02, 2015 , ... Global leader and ... in compression socks designed for men. , For style that’s quick on its ... daily routine. This is great news for men everywhere because a simple change in ...
    (Date:7/2/2015)... ... July 02, 2015 , ... ... 2015” provides comprehensive information on the pipeline products with comparative analysis of ... wound therapy (NPWT) with 22 market data tables and 4 figures, spread ...
    (Date:7/2/2015)... , ... July 02, 2015 , ... ... Tunnel treatment and wrist pain treatment. Dr. Lev Kalika, founder of New ... a leading international authority on the conservative treatment of back, hip, knee and ...
    (Date:7/2/2015)... ... ... Hand sanitizers have become extremely popular with an annual industry growth rate ... and radio host Sharon Kleyne, hand sanitizers can effectively decrease the presence of disease ... must be applied correctly and users must be aware of its limitations. , ...
    (Date:7/2/2015)... ... July 02, 2015 , ... The report summarizes ... manufacturers. The report is a valuable source of guidance and direction for companies ... Chinese market for the Gelatin Capsule industry including capacity, production, production value, cost ...
    Breaking Medicine News(10 mins):Health News:SIGVARIS Kicks Up Its Style for Men with the Launch of MIDTOWN MICROFIBER in a Dark Navy Stripe Pattern 2Health News:SIGVARIS Kicks Up Its Style for Men with the Launch of MIDTOWN MICROFIBER in a Dark Navy Stripe Pattern 3Health News:Negative Pressure Wound Therapy (System, Wound Care, Tissue Cooling NPWT) Pipeline Review 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Negative Pressure Wound Therapy (System, Wound Care, Tissue Cooling NPWT) Pipeline Review 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:Negative Pressure Wound Therapy (System, Wound Care, Tissue Cooling NPWT) Pipeline Review 2015 Market Research Report Available at RnRMarketResearch.com 4Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 2Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 3Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 4Health News:Summer flu season hand sanitizers are most effective when correctly applied reports fresh water advocate Sharon Kleyne 2Health News:Summer flu season hand sanitizers are most effective when correctly applied reports fresh water advocate Sharon Kleyne 3Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 2Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 3Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 4
    ... on Inc. 5000 list ... and new members, DOVER, N.H., Aug. 25 ... Free" atmosphere and friendly prices, earned,the top spot among ... 5,000 fastest-growing private businesses in the United States., ...
    ... consulting with school staff on avoidance strategies , , MONDAY, ... staff need to take measures to ensure the safety ... food allergies, says the American Academy of Allergy, Asthma ... and school staff is a key ingredient to keeping ...
    ... Aug. 25 Researchers at Scripps Translational,Science Institute (STSI) ... of a gene responsible for the majority of inherited ... online Aug. 24 in,Nature., Neuroblastoma -- a cancer ... childhood cancer deaths and has bleak survival probabilities of,less ...
    ... Integrated EHR Leader,s Growth Up 47 Percent from ... Greenway Medical Technologies,Inc., further establishing itself as ... practice management and interoperability,solutions, recently announced a 47 ... ending June 30, 2008, as compared to fiscal ...
    ... General Assembly for Allowing Dependents Ages,19-26 to Get Covered ... The face of a,broken health care system keeps ... are now the largest segment of the population without,health ... to change that by allowing more people in their ...
    ... N.Y., Aug. 25 Reflecting the expanding,scope of ... social, cultural,and environmental factors on health care systems ... Mary Ann Liebert Inc. have renamed,the peer-reviewed journal ... name of the journal (formerly Disease Management) begins ...
    Cached Medicine News:Health News:N.H.-Based Health Club Operator Sets The Industry's Pace 2Health News:Food Allergy Action Plan Can Keep Kids From Harm 2Health News:Scripps Translational Science Institute Contributes to Discovery of Predisposition Gene for Childhood Cancer 2Health News:Greenway Medical Technologies' Growth Continues with Significant Fiscal Year 2008 Gains 2Health News:Greenway Medical Technologies' Growth Continues with Significant Fiscal Year 2008 Gains 3Health News:Younger Adults in Illinois Aided by Expansion of Health Care Coverage 2Health News:Disease Management Journal Changes Name and Expands Focus to Population Health Management 2
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    Medicine Products: